Tag: SEPS
Landiolol Does Not Reduce Organ Failure in Septic Shock Patients With Tachycardia
Mean Sequential Organ Failure Assessment score did not differ for those receiving landiolol and standard care
In-Hospital Mortality Evaluated for SARS-CoV-2-Linked Sepsis
March 2020 to November 2022 saw decline in crude in-hospital mortality for SARS-CoV-2-linked sepsis from 33.4 to 14.9 percent
Factors ID’d That Increase Risk for Mechanical Ventilation With Sepsis
However, risk factors change depending on time from diagnosis and comorbidities
Opportunities Exist for Improving Hospital-Based Sepsis Programs With New CDC Guidance
73 percent of hospitals have a committee that monitors and reviews sepsis care, with prevalence varying by hospital size
Continuous Meropenem No Benefit in Critically Ill Patients With Sepsis
No improvement seen in composite of all-cause mortality and emergence of pandrug- or extensively drug-resistant bacteria
Hydrocortisone Does Not Reduce 90-Day Mortality in Septic Shock
Small reduction in mortality seen with use of hydrocortisone with fludrocortisone
Hydrocortisone Plus Fludrocortisone Superior for Septic Shock
Compared with hydrocortisone alone, combo significantly cuts risk for in-hospital death or hospice discharge
Azithromycin Cuts Maternal Sepsis, Death in Vaginal Delivery
For women planning vaginal delivery, azithromycin linked to lower risk for maternal sepsis or death
Cardiovascular Hospitalization Increased After Sepsis Hospitalization
Patients discharged after sepsis hospitalization have increased risk for all-cause mortality, all-cause rehospitalization
Restrictive, Liberal Fluid Strategies Yield Similar Outcomes for Sepsis-Induced Hypotension
All-cause death before discharge home by day 90 occurred in 14.0 percent of the restrictive fluid group and 14.9 percent in the liberal fluid group
